Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 16

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 58–69

Polypragmasy in elderly and senile patients with chronic kidney disease: START/STOP criteria in elderly and senile patients taking DOAC

Introduction. Thanks to the achievements of modern medicine, it was possible to significantly increase the life expectancy of the population. Molecular mechanisms of aging include telomere shortening, DNA damage accumulation, mitochondrial dysfunction, leading…

10.29296/24999490-2025-05-07Details ↗
ОБЗОР2025 · pp. 19–29

Molecular mechanisms and pharmacogenetic determinants of II–III generation antihistamines efficacy in allergic bronchial asthma: personalized therapy prospects

Introduction. Allergic bronchial asthma (BA) is accompanied by activation of histamine H1/H4 receptors and variable response to antihistamines. The aim of this review is to analyze the molecular mechanisms of action of second- and third-generation antihistamin…

10.29296/24999490-2025-03-03Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

POLYMORPHISM OF VEGF-A GENES AND THE RISK OF THE DEVELOPMENT OF THE EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Introduction. Age-related macular degeneration (AMD), in particular, its exudative form, has for many years held a leading position in the causes of the loss of visual acuity and leads to blindness in 90% of elderly cases. The loss of central vision is based o…

10.29296/24999490-2018-05-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

PHARMACOGENETIC TESTING BY POLYMORPHIC MARKERS G1846A (CYP2D6*4) AND C100T (CYP2D6*10) CYP2D6 GENE IN CORONARY HEART DISEASEPATIENTS, TAKING BETA-BLOCKERS IN THE SAKHA REPUBLIC (YAKUTIA)

Introduction. The aim of this study to determine carrier frequencies of polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease (CHD) patients in Russian and Yakut ethnic groups. The association between theadmin…

10.29296/24999490-2018-04-09Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

THE PREVALENCE OF CYP2C19*2, *3 POLYMORPHISMS AMONG RUSSIANS AND YAKUTS WITH PEPTIC ULCER DISEASE, LIVING IN SAKHA REPUBLIC (YAKUTIA)

Introduction. Proton pump inhibitors (PPI) are widely spread as antisecretory drugs for a treatment of acid diseases, such as the gastric ulcer. Most of the proton pump inhibitors are inactivated in the liver by cytochromes P450 2C19 (CYP2C19) to the form of i…

10.29296/24999490-2018-04-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

THE CYP2C19*2, CYP2C19*3 POLYMORPHISMS ASSOCIATED WITH THE RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SINDROME IN THE YAKUT AND RUSSIAN ETHNIC GROUPS

ntroduction. The aim of this study was to determine the prevalence rate of CYP2C19 alleles, associated with the risk of the resistance to clopidogrel and the development of thrombotic complications in patients with acute coronary syndrome (ACS) from Russian an…

10.29296/24999490-2018-02-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017

CLINICAL SIGNIFICANCE OF GENE CYP2C19 POLYMORPHISM IN STEMI PATIENTS (DATA FROM THE KEMEROVO REGISTRY OF THE ACUTE CORONARY SYNDROME)

Aim is to evaluate distribution and clinical significance of gene CYP2C19 polymorfism in ST-segment elevation myocardial infarction (STEMI) patients. Materials and methods. A total of 159 patients were encluded in this study. All of them underwent primary PCI.…

Details ↗
ОБЗОР2016

PHARMACOGENETIC ASPECTS OF THE EFFICACY AND SAFETY OF HALOPERIDOL IN PATIENTS WITH ADDICTIVE DISORDERS

The use of haloperidol in clinical practice is often accompanied by the development of severe unwanted adverse side effects from the side of various organs and systems. In the narcological practice the use of antipsychotic drugs is not seldom complicated by ex…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

THE INFLUENCE OF FUNCTIONAL POLYMORPHISM IN THE GALANIN PROMOTOR ON GLATIRAMER ACETATE EFFICACY IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

Introduction. Glatiramer acetate (GA, copaxone) – is an immunomodulatory drug, used for reducing the progression of multiple sclerosis. The absence of optimal therapeutic effect in some cases determines the necessity to search the prognostic markers of GA effi…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

GENE SLCO1B1 ASSOCIATED WITH STATIN-INDUCED MYOPATHY IN RUSSIAN AND SAKHA (YAKUTIA) STATIN INTAKE PATIENTS SUFFERED FROM HYPERLIPIDEMIA

Introduction. SLCO1B1 encodes the organic anion-transporting polypeptide which has been shown to regulate the hepatic uptake of statins. SLCO1B1*5 genetic variant is associated with the high risk for statin-induced myopathy in patients with statins therapy. Ai…

Details ↗
ОБЗОР2015

THE PHARMACOGENETIC MECHANISMS OF DEVELOPMENT OF METABOLIC DISORDERS ASSOCIATED WITH THE SECOND-GENERATION ANTIPSYCHOTICS

Antipsychotics are the main medication for schizophrenia treatment. Recently the wideused group of them became second-generation antipsychotics (SGA). Due to that, problem of metabolic disturbances as side effect of SGA is more actually. The development of pha…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

APPLICATION OF PHARMACOGENETICS TESTING IN PATIENTS WITH CARDIAC VALVE REPLACEMENT

Introduction. Pharmacogenetic testing allows of increasing efficacy of anticoagulation therapy, reducing time required for adjusting therapeutic dose, and considerably reducing number of complications. The aim of the study. To investigate the dependence of the…

Details ↗

Article search and quick navigation

Navigation